A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Reference-Cited by-同舟云学术

A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Published:2019-07 Issue: Volume:30 Page:9-18
ISSN:1477-8939
Container-title:Travel Medicine and Infectious Disease
language:en
Short-container-title:Travel Medicine and Infectious Disease

Author:

Momattin Hisham,Al-Ali Anfal Y.,Al-Tawfiq Jaffar A.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference72 articles.

1. Healthcare-associated infections: the hallmark of the Middle East respiratory syndrome coronavirus (MERS-CoV) with review of the literature;Al-Tawfiq;J Hosp Infect,2018

2. Drivers of MERS-CoV transmission: what do we know?;Al-Tawfiq;Expert Rev Respir Med,2016

3. A family cluster of middle east respiratory syndrome coronavirus infections related to a likely unrecognized asymptomatic or mild case;Omrani;Int J Infect Dis,2013

4. Family cluster of Middle East respiratory syndrome coronavirus infections;Memish;N Engl J Med,2013

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus;Virus Research;2024-07

2. Antiviral activity of the host defense peptide piscidin 1: investigating a membrane-mediated mode of action;Frontiers in Chemistry;2024-06-26

3. Harnessing the power of IFN for therapeutic approaches to COVID-19;Journal of Virology;2024-05-14

4. Developments in treatment for middle east respiratory syndrome coronavirus (MERS-CoV);Expert Review of Respiratory Medicine;2024-05-03

5. An in silico approach to develop potential therapies against Middle East Respiratory Syndrome Coronavirus (MERS-CoV);Heliyon;2024-02